Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset Analysis.
Saved in:
| Title: | Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset Analysis. |
|---|---|
| Authors: | Oya M; Keio University Hospital, Tokyo, Japan., Joung JY; Center for Prostate Cancer, National Cancer Center, Goyang, South Korea., Lee JY; Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea., Sugimoto M; Kagawa University Hospital, Kagawa, Japan., Choi YD; Yonsei University College of Medicine, Seoul, South Korea., Hong JH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea., Uemura H; Yokohama City University Medical Center, Yokohama, Japan., Nishimura K; Osaka International Cancer Institute, Osaka, Japan., Tsumura H; Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan., Kawakami S; Saitama Medical Center, Saitama Medical University, Kawagoe, Japan., Hirayama Y; Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan., Kwon TG; Chilgok Kyungpook National University Medical Center, Daegu, South Korea., Kwak C; Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea., Suzuki H; Toho University Sakura Medical Center, Chiba, Japan., Fujita T; AstraZeneca, Osaka, Japan., Nii M; AstraZeneca, Osaka, Japan., McGuinness D; AstraZeneca, Cambridge, UK., Dujka M; AstraZeneca, Gaithersburg, Maryland, USA., Poehlein C; Merck & Co. Inc., Rahway, New Jersey, USA., Saad F; Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada., Clarke N; The Christie and Salford Royal Hospital NHS Foundation Trusts and University of Manchester, Manchester, UK. |
| Source: | Cancer science [Cancer Sci] 2025 Jun; Vol. 116 (6), pp. 1638-1647. Date of Electronic Publication: 2025 Mar 18. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40099663 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset Analysis. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Oya+M%22">Oya M</searchLink>; Keio University Hospital, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Joung+JY%22">Joung JY</searchLink>; Center for Prostate Cancer, National Cancer Center, Goyang, South Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JY%22">Lee JY</searchLink>; Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Sugimoto+M%22">Sugimoto M</searchLink>; Kagawa University Hospital, Kagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Choi+YD%22">Choi YD</searchLink>; Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Hong+JH%22">Hong JH</searchLink>; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Uemura+H%22">Uemura H</searchLink>; Yokohama City University Medical Center, Yokohama, Japan.<br /><searchLink fieldCode="AU" term="%22Nishimura+K%22">Nishimura K</searchLink>; Osaka International Cancer Institute, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Tsumura+H%22">Tsumura H</searchLink>; Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Kawakami+S%22">Kawakami S</searchLink>; Saitama Medical Center, Saitama Medical University, Kawagoe, Japan.<br /><searchLink fieldCode="AU" term="%22Hirayama+Y%22">Hirayama Y</searchLink>; Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Kwon+TG%22">Kwon TG</searchLink>; Chilgok Kyungpook National University Medical Center, Daegu, South Korea.<br /><searchLink fieldCode="AU" term="%22Kwak+C%22">Kwak C</searchLink>; Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Suzuki+H%22">Suzuki H</searchLink>; Toho University Sakura Medical Center, Chiba, Japan.<br /><searchLink fieldCode="AU" term="%22Fujita+T%22">Fujita T</searchLink>; AstraZeneca, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22Nii+M%22">Nii M</searchLink>; AstraZeneca, Osaka, Japan.<br /><searchLink fieldCode="AU" term="%22McGuinness+D%22">McGuinness D</searchLink>; AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Dujka+M%22">Dujka M</searchLink>; AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Poehlein+C%22">Poehlein C</searchLink>; Merck & Co. Inc., Rahway, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Saad+F%22">Saad F</searchLink>; Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Clarke+N%22">Clarke N</searchLink>; The Christie and Salford Royal Hospital NHS Foundation Trusts and University of Manchester, Manchester, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101168776%22">Cancer science</searchLink> [Cancer Sci] 2025 Jun; Vol. 116 (6), pp. 1638-1647. <i>Date of Electronic Publication: </i>2025 Mar 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley+Publishing+on+behalf+of+the+Japanese+Cancer+Association%22">Wiley Publishing on behalf of the Japanese Cancer Association </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101168776 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1349-7006 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213479032%22">13479032 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Sci <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40099663 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/cas.16459 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1638 Titles: – TitleFull: Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset Analysis. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Oya M – PersonEntity: Name: NameFull: Joung JY – PersonEntity: Name: NameFull: Lee JY – PersonEntity: Name: NameFull: Sugimoto M – PersonEntity: Name: NameFull: Choi YD – PersonEntity: Name: NameFull: Hong JH – PersonEntity: Name: NameFull: Uemura H – PersonEntity: Name: NameFull: Nishimura K – PersonEntity: Name: NameFull: Tsumura H – PersonEntity: Name: NameFull: Kawakami S – PersonEntity: Name: NameFull: Hirayama Y – PersonEntity: Name: NameFull: Kwon TG – PersonEntity: Name: NameFull: Kwak C – PersonEntity: Name: NameFull: Suzuki H – PersonEntity: Name: NameFull: Fujita T – PersonEntity: Name: NameFull: Nii M – PersonEntity: Name: NameFull: McGuinness D – PersonEntity: Name: NameFull: Dujka M – PersonEntity: Name: NameFull: Poehlein C – PersonEntity: Name: NameFull: Saad F – PersonEntity: Name: NameFull: Clarke N IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2025 Jun Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1349-7006 Numbering: – Type: volume Value: 116 – Type: issue Value: 6 Titles: – TitleFull: Cancer science Type: main |
| ResultId | 1 |